Effectiveness and Tolerability of 12-Month Brivaracetam in the Real World: EXPERIENCE, an International Pooled Analysis of Individual Patient Records

Sustained seizure freedom with adjunctive brivaracetam in patients with focal onset seizures

(2022) Simona Lattanzi et al.   EPILEPSIA

Retention, efficacy, tolerability, and quality of life during long-term adjunctive brivaracetam treatment by number of lifetime antiseizure medications: A post hoc analysis of phase 3 trials in adults with focal seizures

(2022) Christian Brandt et al.   EPILEPSY & BEHAVIOR

Behavioral adverse events with brivaracetam, levetiracetam, perampanel, and topiramate: A systematic review

(2021) Bernhard J. Steinhoff et al.   EPILEPSY & BEHAVIOR

Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST)

(2021) Simona Lattanzi et al.   CNS DRUGS

Long‐term efficacy, tolerability, and retention of brivaracetam in epilepsy treatment: A longitudinal multicenter study with up to 5 years of follow‐up

(2021) Adam Strzelczyk et al.   EPILEPSIA

Long-term efficacy and tolerability of adjunctive brivaracetam in adults with focal to bilateral tonic-clonic (secondary generalized) seizures: Post hoc pooled analysis

(2021) Brian D. Moseley et al.   EPILEPSY RESEARCH

Efficacy of Brivaracetam in children with epilepsy

(2021) Fernando Ferragut Ferretjans et al.   EPILEPSY RESEARCH

Brivaracetam efficacy and tolerability in clinical practice: A UK-based retrospective multicenter service evaluation

(2020) J. Adewusi et al.   EPILEPSY & BEHAVIOR

Time course of drug-related treatment-emergent adverse side effects of brivaracetam

(2020) Kimford J. Meador et al.   EPILEPSY & BEHAVIOR

Dysautonomia is associated with structural and functional alterations in Parkinson disease

(2019) Seok Jong Chung et al.   NEUROLOGY

Efficacy, retention, and safety of brivaracetam in adult patients with genetic generalized epilepsy

(2019) Elena Fonseca et al.   EPILEPSY & BEHAVIOR

Use of brivaracetam in genetic generalized epilepsies and for acute, intravenous treatment of absence status epilepticus

(2018) Adam Strzelczyk et al.   EPILEPSIA

Brivaracetam in the Treatment of Patients with Epilepsy—First Clinical Experiences

(2018) Felix Zahnert et al.   Frontiers in Neurology

BRIVA-LIFE-A multicenter retrospective study of the long-term use of brivaracetam in clinical practice

(2018) Vicente Villanueva et al.   ACTA NEUROLOGICA SCANDINAVICA

Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology

(2017) Robert S. Fisher et al.   EPILEPSIA

Postmarketing experience with brivaracetam in the treatment of epilepsies: A multicenter cohort study from Germany

(2017) Isabel Steinig et al.   EPILEPSIA

Efficacy and tolerability of adjunctive brivaracetam in patients with prior antiepileptic drug exposure: A post-hoc study

(2017) Ali A. Asadi-Pooya et al.   EPILEPSY RESEARCH

Real-life experience with brivaracetam in 101 patients with difficult-to-treat epilepsy—A monocenter survey

(2017) Bernhard J. Steinhoff et al.   SEIZURE-EUROPEAN JOURNAL OF EPILEPSY

Evidence for a differential interaction of brivaracetam and levetiracetam with the synaptic vesicle 2A protein

(2016) Martyn D. Wood et al.   EPILEPSIA

Efficacy, safety, and tolerability of adjunctive brivaracetam for secondarily generalized tonic-clonic seizures: Pooled results from three Phase III studies

(2016) Brian D. Moseley et al.   EPILEPSY RESEARCH

A randomized, double-blind, placebo-controlled, multicenter, parallel-group study to evaluate the efficacy and safety of adjunctive brivaracetam in adult patients with uncontrolled partial-onset seizures

(2015) Pavel Klein et al.   EPILEPSIA

An open-label, prospective, exploratory study of patients with epilepsy switching from levetiracetam to brivaracetam

(2015) Stephen L. Yates et al.   EPILEPSY & BEHAVIOR

Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: A phase III randomized, double-blind, placebo-controlled trial

(2013) Victor Biton et al.   EPILEPSIA

Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: Results from a double-blind, randomized, placebo-controlled trial

(2013) Philippe Ryvlin et al.   EPILEPSIA

Assessing the Comparative Effectiveness of Newly Marketed Medications: Methodological Challenges and Implications for Drug Development

(2011) S Schneeweiss et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS